Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Biogen (United Kingdom), United Kingdom, covering academic research published from 2001 to 2023. Read More.
Open Access Percentage
48%
Total
Publications
189
Total Open
Publications
91
Total
Citations
3.8K
Open Access
Percentage
48%
Total
Publications
189
Total Open
Publications
91
Total
Citations
3.8K
Breakdown
Publisher Open
18%
Both
26%
Other Platform Open
4%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
24
Hybrid 46%
39
No Guarantees 25%
21
Other Platform Open
Domain 91%
51
Institution 20%
11
Public 4%
2
Other Internet 2%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 51 |
Europe PMC | Domain | 21 |
Universität Bielefeld - archived repository - Publikationen an der Universität Bielefeld - archived repository | Institution | 2 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 2 |
University College London - UCL Discovery | Institution | 2 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 2 |
Semantic Scholar | Public | 2 |
Elsevier - Scopus | Other Internet | 2 |
Würzburg University - Online Publication Service of Würzburg University | Institution | 1 |
wustl.edu OAI-PMH Repository | Institution | 1 |